FibroBiologics Inc. Common Stock (FBLG)
Stock · NASDAQ · Health Care
$1.44as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$1.08
Industry
Biotechnology: Pharmaceutical Preparations
Fundamentals
- Market cap
- $4.81M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
FibroBiologics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- FBLGFibroBiologics Inc. Common Stock$1.44▼ 3.36%Market cap $4.81MP/E —
- APVOAptevo Therapeutics Inc. Common Stock$2.36▼ 2.48%Market cap $4.92MP/E 0.00$2.3$48.78
- LABTLakewood-Amedex Biotherapeutics Inc. Common Stock$2.3▼ 4.56%Market cap $5.28MP/E —$0.366$9.82
- GOVXGeoVax Labs Inc. Common Stock$0.7195▲ 0.35%Market cap $5.34MP/E —$0.59$19.2
- BGMSBio Green Med Solution Inc. Common Stock$0.86▼ 3.37%Market cap $5.35MP/E 0.18$0.5664$8.82
- ZSTKZeroStack Corp. Common Stock$5.51▼ 6.29%Market cap $4.21MP/E —$1.32$47
- INMInMed Pharmaceuticals Inc. Common Shares$1.43▼ 0.35%Market cap $4.09MP/E —$0.575$2.5
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| FBLG FibroBiologics Inc. Common Stock | $4.81M | — | $1.44 | ▼ 3.36% | |
| APVO Aptevo Therapeutics Inc. Common Stock | $4.92M | 0.00 | $2.36 | ▼ 2.48% | $2.3$48.78 |
| LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock | $5.28M | — | $2.3 | ▼ 4.56% | $0.366$9.82 |
| GOVX GeoVax Labs Inc. Common Stock | $5.34M | — | $0.7195 | ▲ 0.35% | $0.59$19.2 |
| BGMS Bio Green Med Solution Inc. Common Stock | $5.35M | 0.18 | $0.86 | ▼ 3.37% | $0.5664$8.82 |
| ZSTK ZeroStack Corp. Common Stock | $4.21M | — | $5.51 | ▼ 6.29% | $1.32$47 |
| INM InMed Pharmaceuticals Inc. Common Shares | $4.09M | — | $1.43 | ▼ 0.35% | $0.575$2.5 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- FibroBiologics Says Preclinical Data Shapes Design of Further Studies for Degenerative Joint TreatmentBenzinga · 8/18/2026
- FibroBiologics' Preclinical Trial Of Degenerative Joints Demonstrates Chondrocyte Spheroids Repairs CartilageBenzinga · 8/18/2026
- FibroBiologics Says USPTO Issues US Patent Entitled Methods And Compositions For Treatment Of Type 1 Diabetes Using Fibroblasts In Facilitation Of Islet EngraftmentBenzinga · 8/11/2026
- FibroBiologics Receives Patent From European Patent Office For Its Gene Therapy For The Regeneration Of Chondrocytes Or Cartilage Type CellsBenzinga · 8/5/2026
- Snap To Rally More Than 217%? Here Are 10 Top Analyst Forecasts For TuesdayBenzinga · 8/4/2026
- HC Wainwright & Co. Maintains Buy on FibroBiologics, Lowers Price Target to $6Benzinga · 8/4/2026
- FibroBiologics, Inc. - Common Stock Q2 EPS $(0.66) Beats $(0.72) EstimateBenzinga · 7/31/2026
Insider Activity
Insider Actions →Acquired
551.9K
Disposed
0
- Cilento Richard C. Jr. · June 23, 2026 · Grant30.8K
- Niklas Victoria Ninon Olivia · June 23, 2026 · Grant30.8K
- Link Matthew · June 23, 2026 · Grant30.8K
- Robert E. Hoffman · June 23, 2026 · Grant30.8K
- Khoja Hamid · May 4, 2026 · Grant61.6K
- GARCIA RUBEN A · May 4, 2026 · Grant61.6K
- O'HEERON PETE · May 4, 2026 · Grant92.4K
- Davis Jason · May 4, 2026 · Grant61.6K
- Khoja Hamid · March 4, 2026 · Buy30.0K @ $0.38
- O'HEERON PETE · March 4, 2026 · Buy15.9K @ $0.3784
- O'HEERON PETE · March 3, 2026 · Buy18.2K @ $0.4051
- O'HEERON PETE · March 2, 2026 · Buy17.4K @ $0.353
- Davis Jason · March 2, 2026 · Buy70.0K @ $0.4139
Institutional Ownership
March 31, 2026
- Total shares held
- 213.1K
- Total value held
- $281.1K
- Institutional holders
- 15
Top holders this quarter
- Unknown67.7K
- Unknown51.8K
- Unknown29.6K
- Unknown24.6K
- Unknown16.4K
- Unknown16.0K
- Unknown5.7K
- Unknown460
- Unknown200
- Unknown186
See the full, filterable feed with live charts on the MarketWall dashboard.